Newsfile
搜索文档
ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
Newsfile· 2025-11-21 03:11
ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX November 20, 2025 2:11 PM EST | Source: The Rosen Law Firm PA New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of t ...
Attention Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office is Investigating Claims on Your Behalf
Newsfile· 2025-11-21 02:55
Attention Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office is Investigating Claims on Your BehalfNovember 20, 2025 1:55 PM EST | Source: Grabar Law OfficePhiladelphia, Pennsylvania--(Newsfile Corp. - November 20, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.Curr ...
Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny-- Hagens Berman
Newsfile· 2025-11-21 02:30
Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny-- Hagens BermanSNPS Investors with Losses Encouraged to Contact Hagens BermanNovember 20, 2025 1:30 PM EST | Source: Hagens Berman Sobol Shapiro LLPSan Francisco, California--(Newsfile Corp. - November 20, 2025) - Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted by the recent departure of its Chief Reve ...
IMPACT Silver Intersects 15.14% ZnEq over 3.07m Including 24.69% ZnEq over 1.47m at the Plomosas Mine
Newsfile· 2025-11-21 02:26
IMPACT Silver Intersects 15.14% ZnEq over 3.07m Including 24.69% ZnEq over 1.47m at the Plomosas MineNovember 20, 2025 1:26 PM EST | Source: IMPACT Silver Corp.Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - IMPACT Silver Corp. (TSXV: IPT) (OTCQB: ISVLF) (FSE: IKL) ("IMPACT" or the "Company") is pleased to announce further results from its underground drill program in the Juarez Zone at its Plomosas zinc (lead-silver) Mine in northern Mexico. JUAREZ ZONE DRILLINGNew drill i ...
KMX SHAREHOLDER NOTICE: CarMax, Inc. (KMX) Class Period in Securities Class Action Expanded Amid CEO Termination -- Hagens Berman
Newsfile· 2025-11-21 02:22
San Francisco, California--(Newsfile Corp. - November 20, 2025) - A new securities class action lawsuit against CarMax, Inc. (NYSE: KMX) has expanded the alleged class period to now include investors who purchased or otherwise acquired CarMax securities between June 20, 2025 and November 5, 2025.The period has been lengthened to include the severe market reaction to CarMax's announcement that it fired CEO Bill Nash, news which drove the price of CarMax shares down as much as $9.48 (-23%) on November 6, 202 ...
Giga Metals Corp. Presents in Existing Agency's Virtual Webinar Series
Newsfile· 2025-11-21 02:12
Toronto, Ontario--(Newsfile Corp. - November 20, 2025) - Giga Metals Corp. (TSXV: GIGA) (OTCQB: GIGGF) (FSE: BRR2) is pleased to announce that the company is presenting a live virtual corporate update hosted by Existing Agency Inc. on December 3 at 2:00 PM ET.Existing Agency invites current shareholders, and all interested parties to register for the webinar and participate in the live Q&A session at the end of the presentation moderated by Existing Agency Inc. The replay will be emailed out to all webinar ...
ROSEN, A LEADING LAW FIRM, Encourages Nidec Corporation Investors to Inquire About Securities Class Action Investigation - NJDCY
Newsfile· 2025-11-21 02:01
New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Nidec Corporation (OTC: NJDCY) resulting from allegations that Nidec Corporation may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Nidec Corporation securities you may be entitled to compensation without payment of any out of pocket fees or costs thr ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKYE
Newsfile· 2025-11-21 01:59
New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026.SO WHAT: If you purchased Skye securities during the C ...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO
Newsfile· 2025-11-21 01:49
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGONovember 20, 2025 12:49 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inc ...
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.
Newsfile· 2025-11-21 01:26
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.November 20, 2025 12:26 PM EST | Source: PreveCeutical Medical Inc.Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its news release of earlier today, the Company wishes to clarify that shareholders of record of November 24, 20 ...